SXTPW 60 DEGREES PHARMACEUTICALS I
Follow*W EXP 07/12/202 (warrant or right), issuer CIK 1946563
6 managers (6 13F filers) reported a position in SXTPW shares at 2025-06-30, 435,231 shares in all. 1 filer opened a position and 2 filers sold out during the quarter.
- Managers
- 6
- 13F filers
- 6
- New
- 1
- Added
- 0
- Reduced
- 2
- Sold out
- 2
- Shares held by filers
- 435,231
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2025
Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Walleye Capital LLCin group Walleye Capital LLC | 222,906 | $12.6K | <0.01% | 0 | 13F-HRTimelineGroup |
| CLEAR STREET LLC | 145,987 | $8.23K | <0.01% | -200 | 13F-HRTimeline |
| TORNO CAPITAL, LLC | 47,169 | $2.66K | <0.01% | 0 | 13F-HR/ATimeline |
| CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC | 17,668 | $783 | <0.01% | -24,754 | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 1,501 | $62 | <0.01% | new | 13F-HRTimelineGroup |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | 0 | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |